Acrivon Therapeutics (ACRV) Other financing activities (as filed) (2022 - 2026)
Acrivon Therapeutics (ACRV) posted Other financing activities of $34,000 for Q2 2026, down 64.9% from $97,000 a year earlier but up 3.0% from the prior quarter.
Powered by 
Analysis
Acrivon Therapeutics (ACRV) Other financing activities (as filed) (2022 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Other financing activities at Acrivon Therapeutics was $376,000, down 83.5% year-over-year; for FY2025, it came in at $750,000, down 70.2% from FY2024.
- In prior years, Acrivon Therapeutics' Other financing activities was $2.52 million in FY2024 (+94.3%) and $1.3 million in FY2023.
- Quarterly Other financing activities has run from a low of $33,000 in Q1 2026 to a high of $1.2 million in Q3 2024 over five years.
- On a year-over-year basis, Other financing activities has declined in each of the last five quarters, with an average decline of 48.3% over the last six quarters.
- According to Business Quant data, Other financing activities for the three prior quarters was $33,000 (Q1 2026), $192,000 (Q4 2025) and $117,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Acrivon Therapeutics | 67.27 Mn | -368.26 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -38,000.00 |
| Mar 31, 2026 | -33,000.00 |
| Dec 31, 2025 | -192,000.00 |
| Sep 30, 2025 | -117,000.00 |
| Jun 30, 2025 | -97,000.00 |
| Mar 31, 2025 | -344,000.00 |
| Dec 31, 2024 | -647,000.00 |
| Sep 30, 2024 | -1.50 Mn |
| Jun 30, 2024 | -6.66 Mn |
| Mar 31, 2024 | -251,000.00 |
| Dec 31, 2022 | -2.95 Mn |
| Sep 30, 2022 | 186,000.00 |
API Access
Acrivon Therapeutics Other financing activities (as filed) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-financing-activities&ticker=ACRV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-financing-activities", "ticker": "ACRV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-financing-activities&ticker=ACRV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();